Viser 1 - 50 av 278 resultater
Tid Selskap Tittel Sektor Kategori
28 Apr 2021
18:00 CEST
QUANTUM GENOMICS Quantum Genomics Secures 3 Million euros Non-dilutive Financing 20103010 Biotechnology Other subject
28 Apr 2021
18:00 CEST
QUANTUM GENOMICS Obtention de financements non-dilutifs de 3 millions d'euros 20103010 Biotechnology Other subject
27 Apr 2021
18:00 CEST
QUANTUM GENOMICS 2020 annual report 20103010 Biotechnology Legal
21 Apr 2021
08:00 CEST
QUANTUM GENOMICS Quantum Genomics will Present Top-line Results from its QUORUM study of Firibastat in Heart Failure post Myocardial Infarction at the European Society of Cardiology (ESC) Meeting 20103010 Biotechnology Sales, Income, Commercial results
21 Apr 2021
08:00 CEST
QUANTUM GENOMICS Quantum Genomics présentera les premiers résultats de son étude QUORUM dans l'insuffisance cardiaque après Infarctus du Myocarde avec Firibastat lors du congrès de la Société Européenne de Cardiologie (ESC). 20103010 Biotechnology Sales, Income, Commercial results
21 Apr 2021
08:00 CEST
QUANTUM GENOMICS Quantum Genomics présentera les premiers résultats de son étude QUORUM dans l'insuffisance cardiaque après Infarctus du Myocarde avec Firibastat lors du congrès de la Société Européenne de Cardiologie (ESC). 20103010 Biotechnology Sales, Income, Commercial results
21 Apr 2021
08:00 CEST
QUANTUM GENOMICS Quantum Genomics will Present Top-line Results from its QUORUM study of Firibastat in Heart Failure post Myocardial Infarction at the European Society of Cardiology (ESC) Meeting 20103010 Biotechnology Sales, Income, Commercial results
21 Apr 2021
08:00 CEST
QUANTUM GENOMICS Quantum Genomics will Present Top-line Results from its QUORUM study of Firibastat in Heart Failure post Myocardial Infarction at the European Society of Cardiology (ESC) Meeting 20103010 Biotechnology Sales, Income, Commercial results
21 Apr 2021
08:00 CEST
QUANTUM GENOMICS Quantum Genomics présentera les premiers résultats de son étude QUORUM dans l'insuffisance cardiaque après Infarctus du Myocarde avec Firibastat lors du congrès de la Société Européenne de Cardiologie (ESC). 20103010 Biotechnology Sales, Income, Commercial results
20 Apr 2021
08:00 CEST
QUANTUM GENOMICS Quantum Genomics announces the end of its collaboration with Chinese Pharma Qilu in the development and commercialization of firibastat in China 20103010 Biotechnology Other subject
20 Apr 2021
08:00 CEST
QUANTUM GENOMICS Quantum Genomics annonce la fin de la collaboration relative au développement et à la commercialisation du firibastat en Chine avec le laboratoire chinois Qilu Pharmaceutical 20103010 Biotechnology Other subject
14 Apr 2021
18:00 CEST
QUANTUM GENOMICS Information relative au nombre total de droits de vote et d'actions composant le capital 20103010 Biotechnology Other subject
25 Mar 2021
18:00 CET
QUANTUM GENOMICS Quantum Genomics publie ses résultats de l'exercice 2020 et fait le point sur son activité 20103010 Biotechnology Sales, Income, Commercial results
25 Mar 2021
18:00 CET
QUANTUM GENOMICS Rapport financier annuel 2020 20103010 Biotechnology Legal
25 Mar 2021
18:00 CET
QUANTUM GENOMICS Quantum Genomics Reports Full Year 2020 Operating and Financial Results 20103010 Biotechnology Sales, Income, Commercial results
25 Mar 2021
18:00 CET
QUANTUM GENOMICS Quantum Genomics publie ses résultats de l'exercice 2020 et fait le point sur son activité 20103010 Biotechnology Sales, Income, Commercial results
25 Mar 2021
18:00 CET
QUANTUM GENOMICS Quantum Genomics publie ses résultats de l'exercice 2020 et fait le point sur son activité 20103010 Biotechnology Sales, Income, Commercial results
25 Mar 2021
18:00 CET
QUANTUM GENOMICS Quantum Genomics Reports Full Year 2020 Operating and Financial Results 20103010 Biotechnology Sales, Income, Commercial results
25 Mar 2021
18:00 CET
QUANTUM GENOMICS Quantum Genomics Reports Full Year 2020 Operating and Financial Results 20103010 Biotechnology Sales, Income, Commercial results
05 Mar 2021
18:00 CET
QUANTUM GENOMICS Information relative au nombre total de droits de vote et d'actions composant le capital 20103010 Biotechnology Change in Capital
09 Feb 2021
18:00 CET
QUANTUM GENOMICS Orient EuroPharma (OEP) entre au capital de Quantum Genomics 20103010 Biotechnology Other subject
09 Feb 2021
18:00 CET
QUANTUM GENOMICS Orient EuroPharma Acquires Equity Stake in Quantum Genomics 20103010 Biotechnology Other subject
18 Jan 2021
08:00 CET
QUANTUM GENOMICS Lancement de l'Essai REFRESH, Étude Pivotale de Phase III dans l'Hypertension Artérielle Difficile à Traiter/Résistante avec le firibastat en une prise par jour 20103010 Biotechnology Other subject
18 Jan 2021
08:00 CET
QUANTUM GENOMICS Quantum Genomics Launches Phase III Pivotal REFRESH Study in Difficult-to-treat/Resistant Hypertension with Once-a-day Formulation of Firibastat 20103010 Biotechnology Other subject
12 Jan 2021
18:00 CET
QUANTUM GENOMICS Lettre aux Actionnaires 20103010 Biotechnology Other subject
05 Jan 2021
18:00 CET
QUANTUM GENOMICS Bilan au 31 décembre 2020 du contrat de liquidité contracté avec la Société de Bourse Gilbert Dupont 20103010 Biotechnology Other subject
17 Dec 2020
18:00 CET
QUANTUM GENOMICS Information relative au nombre total de droits de vote et d'actions composant le capital 20103010 Biotechnology Change in Capital
16 Dec 2020
08:00 CET
QUANTUM GENOMICS Quantum Genomics signe un contrat stratégique avec Delpharm 20103010 Biotechnology Other subject
16 Dec 2020
08:00 CET
QUANTUM GENOMICS Quantum Genomics Signs a Strategic Contract with Delpharm 20103010 Biotechnology Other subject
15 Dec 2020
08:00 CET
QUANTUM GENOMICS Quantum Genomics conclut un accord de licence et de collaboration exclusif avec Faran 20103010 Biotechnology Other subject
15 Dec 2020
08:00 CET
QUANTUM GENOMICS Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with Faran 20103010 Biotechnology Other subject
03 Dec 2020
08:15 CET
QUANTUM GENOMICS Very successfull Private Placement 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
03 Dec 2020
08:15 CET
QUANTUM GENOMICS Vif succès du Placement Privé 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
03 Dec 2020
08:15 CET
QUANTUM GENOMICS Very successfull Private Placement 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
03 Dec 2020
08:15 CET
QUANTUM GENOMICS Vif succès du Placement Privé 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
02 Dec 2020
17:45 CET
QUANTUM GENOMICS Quantum Genomics structure son capital et renforce sa visibilité financière 20103010 Biotechnology Other subject
02 Dec 2020
17:45 CET
QUANTUM GENOMICS Quantum Genomics Strengthens its Capital Structure and Financial Visibility 20103010 Biotechnology Other subject
02 Dec 2020
17:40 CET
QUANTUM GENOMICS Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with DongWha Pharm 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
02 Dec 2020
17:40 CET
QUANTUM GENOMICS Quantum Genomics conclut un accord de licence et de collaboration exclusif avec DongWha Pharm 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
02 Dec 2020
17:40 CET
QUANTUM GENOMICS Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with DongWha Pharm 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
02 Dec 2020
17:40 CET
QUANTUM GENOMICS Quantum Genomics conclut un accord de licence et de collaboration exclusif avec DongWha Pharm 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
02 Nov 2020
18:00 CET
QUANTUM GENOMICS Quantum Genomics Announces End of Financing Agreement with Negma Group Ltd/Park Partners 20103010 Biotechnology Other subject
02 Nov 2020
18:00 CET
QUANTUM GENOMICS Fin du financement conclu avec Negma Group Ltd / Park Partners 20103010 Biotechnology Other subject
28 Oct 2020
08:00 CET
QUANTUM GENOMICS Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with Xediton Pharmaceuticals 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
28 Oct 2020
08:00 CET
QUANTUM GENOMICS Quantum Genomics conclut un accord de licence et de collaboration exclusif avec Xediton Pharmaceuticals 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
28 Oct 2020
08:00 CET
QUANTUM GENOMICS Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with Xediton Pharmaceuticals 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
28 Oct 2020
08:00 CET
QUANTUM GENOMICS Quantum Genomics conclut un accord de licence et de collaboration exclusif avec Xediton Pharmaceuticals 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
19 Oct 2020
08:00 CEST
QUANTUM GENOMICS Quantum Genomics conclut un accord de licence et de collaboration exclusif avec Qilu Pharmaceutical 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
19 Oct 2020
08:00 CEST
QUANTUM GENOMICS Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with Qilu Pharmaceutical 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
19 Oct 2020
08:00 CEST
QUANTUM GENOMICS Quantum Genomics conclut un accord de licence et de collaboration exclusif avec Qilu Pharmaceutical 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts